Neuromuscular-targeting compound 1

• UNSPSC Description:

  Neuromuscular-targeting compound 1, extracted from patent WO2009099594 A1, Paragraph 0100, is useful in treatment of neuromuscular diseases.

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/2H-Imidazo[4,5-b]pyridin-2-one,_6-chloro-1-_1-ethylpropyl_-1,3-dihydro-7-_2H-tetrazol-5-yl_-.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1NC2=NC=C(Cl)C(C3=NNN=N3)=C2N1C(CC)CC

• Molecular Weight:

  307.74

• References & Citations:

  [1]YANG, Zhe, et al. CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS. WO2009099594A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1178978-20-5